244 related articles for article (PubMed ID: 24807333)
1. Association of combined first-trimester screen and noninvasive prenatal testing on diagnostic procedures.
Larion S; Warsof SL; Romary L; Mlynarczyk M; Peleg D; Abuhamad AZ
Obstet Gynecol; 2014 Jun; 123(6):1303-1310. PubMed ID: 24807333
[TBL] [Abstract][Full Text] [Related]
2. Uptake of noninvasive prenatal testing at a large academic referral center.
Larion S; Warsof SL; Romary L; Mlynarczyk M; Peleg D; Abuhamad AZ
Am J Obstet Gynecol; 2014 Dec; 211(6):651.e1-7. PubMed ID: 24954652
[TBL] [Abstract][Full Text] [Related]
3. Population-based trends in invasive prenatal diagnosis for ultrasound-based indications: two decades of change from 1994 to 2016.
Lostchuck E; Poulton A; Halliday J; Hui L
Ultrasound Obstet Gynecol; 2019 Apr; 53(4):503-511. PubMed ID: 29877030
[TBL] [Abstract][Full Text] [Related]
4. National decline in invasive prenatal diagnostic procedures in association with uptake of combined first trimester and cell-free DNA aneuploidy screening.
Robson SJ; Hui L
Aust N Z J Obstet Gynaecol; 2015 Oct; 55(5):507-10. PubMed ID: 26259499
[TBL] [Abstract][Full Text] [Related]
5. Risk of fetal loss associated with invasive testing following combined first-trimester screening for Down syndrome: a national cohort of 147,987 singleton pregnancies.
Wulff CB; Gerds TA; Rode L; Ekelund CK; Petersen OB; Tabor A;
Ultrasound Obstet Gynecol; 2016 Jan; 47(1):38-44. PubMed ID: 26581188
[TBL] [Abstract][Full Text] [Related]
6. Is nuchal translucency screening associated with different rates of invasive testing in an older obstetric population?
Chasen ST; McCullough LB; Chervenak FA
Am J Obstet Gynecol; 2004 Mar; 190(3):769-74. PubMed ID: 15042012
[TBL] [Abstract][Full Text] [Related]
7. Invasive prenatal diagnostic practice in Denmark 1996 to 2006.
Vestergaard CH; Lidegaard Ø; Tabor A
Acta Obstet Gynecol Scand; 2009; 88(3):362-5. PubMed ID: 19172424
[TBL] [Abstract][Full Text] [Related]
8. Chorionic Villus Sampling, Early Amniocentesis, and Termination of Pregnancy Without Diagnostic Testing: Comparison of Fetal Risk Following Positive Non-invasive Prenatal Testing.
Zelig CM; Knutzen DM; Ennen CS; Dolinsky BM; Napolitano PG
J Obstet Gynaecol Can; 2016 May; 38(5):441-445.e2. PubMed ID: 27261219
[TBL] [Abstract][Full Text] [Related]
9. Noninvasive prenatal testing: impact on genetic counseling, invasive prenatal diagnosis, and trisomy 21 detection.
Wax JR; Cartin A; Chard R; Lucas FL; Pinette MG
J Clin Ultrasound; 2015 Jan; 43(1):1-6. PubMed ID: 25303161
[TBL] [Abstract][Full Text] [Related]
10. The impact of first trimester screening and early fetal anomaly scan on invasive testing rates in women with advanced maternal age.
Hagen A; Entezami M; Gasiorek-Wiens A; Albig M; Becker R; Knoll U; Stumm M; Wegner RD
Ultraschall Med; 2011 Jun; 32(3):302-6. PubMed ID: 20972947
[TBL] [Abstract][Full Text] [Related]
11. The impact of maternal serum screening on the birth prevalence of Down's syndrome and the use of amniocentesis and chorionic villus sampling in South Australia.
Cheffins T; Chan A; Haan EA; Ranieri E; Ryall RG; Keane RJ; Byron-Scott R; Scott H; Gjerde EM; Nguyen AM; Ford JH; Sykes S
BJOG; 2000 Dec; 107(12):1453-9. PubMed ID: 11192100
[TBL] [Abstract][Full Text] [Related]
12. Use of the Combined First-Trimester Screen in High- and Low-Risk Patient Populations After Introduction of Noninvasive Prenatal Testing.
Larion S; Warsof SL; Romary L; Mlynarczyk M; Peleg D; Abuhamad AZ
J Ultrasound Med; 2015 Aug; 34(8):1423-8. PubMed ID: 26206828
[TBL] [Abstract][Full Text] [Related]
13. Impact of introducing a national policy for prenatal Down syndrome screening on the diagnostic invasive procedure rate in England.
Morgan S; Delbarre A; Ward P
Ultrasound Obstet Gynecol; 2013 May; 41(5):526-9. PubMed ID: 23297122
[TBL] [Abstract][Full Text] [Related]
14. Gradual implementation of first trimester screening in a population with a prior screening strategy: population based cohort study.
Calda P; Sípek A; Gregor V
Acta Obstet Gynecol Scand; 2010 Aug; 89(8):1029-33. PubMed ID: 20524903
[TBL] [Abstract][Full Text] [Related]
15. Utilization of noninvasive prenatal testing: impact on referrals for diagnostic testing.
Williams J; Rad S; Beauchamp S; Ratousi D; Subramaniam V; Farivar S; Pisarska MD
Am J Obstet Gynecol; 2015 Jul; 213(1):102.e1-102.e6. PubMed ID: 25882918
[TBL] [Abstract][Full Text] [Related]
16. Trends in timing of prenatal diagnosis and abortion for fetal chromosomal abnormalities.
Hume H; Chasen ST
Am J Obstet Gynecol; 2015 Oct; 213(4):545.e1-4. PubMed ID: 26070711
[TBL] [Abstract][Full Text] [Related]
17. Fetal loss rate and associated risk factors after amniocentesis, chorionic villus sampling and fetal blood sampling.
Enzensberger C; Pulvermacher C; Degenhardt J; Kawacki A; Germer U; Gembruch U; Krapp M; Weichert J; Axt-Fliedner R
Ultraschall Med; 2012 Dec; 33(7):E75-E79. PubMed ID: 22623130
[TBL] [Abstract][Full Text] [Related]
18. Utilization of available prenatal screening and diagnosis: effects of the California screen program.
Blumenfeld YJ; Taylor J; Lee HC; Hudgins L; Sung JF; El-Sayed YY
J Perinatol; 2012 Dec; 32(12):907-12. PubMed ID: 22402484
[TBL] [Abstract][Full Text] [Related]
19. Declining invasive prenatal diagnostic procedures: A comparison of tertiary hospital and national data from 2012 to 2015.
Johnson K; Kelley J; Saxton V; Walker SP; Hui L
Aust N Z J Obstet Gynaecol; 2017 Apr; 57(2):152-156. PubMed ID: 28295165
[TBL] [Abstract][Full Text] [Related]
20. Socioeconomic disparities in diagnostic testing after positive aneuploidy screening.
Wong AE; Dungan J; Feinglass J; Grobman WA
Am J Perinatol; 2015 Feb; 30(2):205-10. PubMed ID: 24936938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
